Therapy News and Research

RSS

Effectiveness of a cognitive-behavioral treatment program for chronic insomnia

A majority of people experiencing chronic insomnia can experience a normalization of sleep parameters through the use of cognitive behavioral therapy for insomnia (CBT-I), according to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.

9 Jun 2009

Diabetes with coronary disease: A moving target amid evolving therapies

In an editorial in the current issue of the New England Journal of Medicine (NEJM), William E. Boden, M.D., professor of medicine and preventive medicine at the University at Buffalo, recommends that the results of the BARI-2D Trial published in that edition must be interpreted with "considerable caution."

8 Jun 2009

Discovery 'significant step' in understanding leukaemia drug resistance

Scientists have pinpointed an enzyme responsible for breaking down and inactivating a key childhood leukaemia drug, which could help to explain why around 20 per cent of patients do not respond to therapy. Their findings are published in the Journal of Clinical Investigation.

8 Jun 2009

HCV protease inhibitor telaprevir improves response, halves treatment time for hepatitis C patients

For patients with the most common form of hepatitis C, the addition of a hepatitis C-specific protease inhibitor called telaprevir to the current standard therapy can significantly improve the chances of being cured, and it does it in half the time of standard therapy alone.

5 Jun 2009

Industry leaders offer solutions for health care reform

The Chicago Tribune published a series of articles on industry's solutions for health care reform. The paper "turned to Chicago-area leaders in three key segments of the industry: insurers, medical providers and pharmacy," and presented their "thoughts on how best to expand medical-care coverage to all Americans."

5 Jun 2009

Economic downturn pushes cost of medicines up, pharmacists lobby for reform role

"Even with the Medicare drug benefit, even with the prevalence of low-cost generics, even with loss-leader discounting by big chains, many Americans still find themselves unable to afford the prescription medications that manage their life-threatening conditions," The New York Times reports.

4 Jun 2009

Experimental drug five times more effective against MDR-TB than conventional therapy

A Johnson & Johnson-run study found that its experimental drug TMC207 could make conventional tuberculosis treatment five times more effective against multi-drug resistant TB (MDR-TB) because it cleared traces of the TB bacteria in the sputum of 48 percent of study volunteers after eight weeks, Reuters reports (Emery, Reuters, 6/3). The results were published on Wednesday in the New England Journal of Medicine.

4 Jun 2009

Rhes protein responsible for brain cell damage in Huntington disease

Johns Hopkins brain scientists have figured out why a faulty protein accumulates in cells everywhere in the bodies of people with Huntington's disease (HD), but only kills cells in the part of the brain that controls movement, causing negligible damage to tissues elsewhere.

4 Jun 2009

Discovery of critical marker of response to gemcitabine in pancreatic cancer

A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson University.

4 Jun 2009

Comprehensive review on sulfonylureas in the latest issue of Diabetic Hypoglycemia

The latest issue of the online journal Diabetic Hypoglycemia features an authoritative review on sulfonylureas by Professor Ian Campbell, a leading expert in oral hypoglycemia therapy.

4 Jun 2009

Prophylactic cranial irradiation prevents early lung cancer metastases to the brain

A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual meeting in Orlando, June 1.

3 Jun 2009

Research looks at relationship between death rates from lung cancer and how much a person smoked

It's common knowledge that smoking raises risks of lung cancer. And yet researchers haven't known whether continued smoking by lung cancer patients would increase the risk of the cancer's spread.

3 Jun 2009

Research questions standard protocol for treating traumatic brain injury

Traumatic brain injury - not heart disease, stroke or cancer - is the number one cause of death and disability in people under 45. Each year, some 1.5 million Americans, including soldiers, athletes, the elderly and children, sustain head injuries, and nearly half of them will be hospitalized and treated in an emergency room or intensive care unit.

3 Jun 2009

Diet low in fat and red meat and high in fruit and veg helps prevent prostate cancer

A new review published in the Journal of Human Nutrition and Dietetics assessed whether certain modifications in diet have a beneficial effect on the prevention of prostate cancer.

3 Jun 2009

SmartPill capsule for ulcerative colitis patients

An electronic diagnostic tool called the SmartPill is swallowed by patients in order to take measurements as it travels through the gastrointestinal tract.

3 Jun 2009

Simple MRI test involving breathing oxygen helps determine cancer therapy success

A simple magnetic resonance imaging (MRI) test involving breathing oxygen might help oncologists determine the best treatment for some cancer patients, report researchers at UT Southwestern Medical Center.

3 Jun 2009

Internet-based programs effective in treating depression – new study

In a discovery that could lead to new treatment approaches for depression, researchers from the University of New South Wales (UNSW) have shown that internet-based therapy programs are as effective as face-to-face therapies in combating the illness.

2 Jun 2009

Bringing life back into the bedroom for cancer survivors

For the more than 6 million female cancer survivors living in the U.S. today, the celebration of continued life and love can be interrupted by cancer treatment's side effects, including in the bedroom. Experts at The University of Texas M. D. Anderson Cancer Center offer survivors advice on how to get their relationships back on track.

2 Jun 2009

New insights into locally advanced breast cancer

Scientists are reporting two findings that could influence the way researchers screen for, treat and assess prognosis for women with locally advanced breast cancer, an aggressive form of the disease. One finding offers a critical message regarding treatment strategy, they say.

2 Jun 2009

External beam partial breast irradiation most cost-effective treatment for women with early-stage breast cancer

External beam partial breast irradiation (EB-PBI) is the most cost-effective method for treating postmenopausal women with early-stage breast cancer based on utilities, recurrence risks and costs when compared to whole breast radiotherapy (WBRT) and brachytherapy partial breast irradiation (brachy-PBI), according to a study in the June 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

2 Jun 2009

Therapy News and Research

Effectiveness of a cognitive-behavioral treatment program for chronic insomnia

Diabetes with coronary disease: A moving target amid evolving therapies

Discovery 'significant step' in understanding leukaemia drug resistance

HCV protease inhibitor telaprevir improves response, halves treatment time for hepatitis C patients

Industry leaders offer solutions for health care reform

Economic downturn pushes cost of medicines up, pharmacists lobby for reform role

Experimental drug five times more effective against MDR-TB than conventional therapy

Rhes protein responsible for brain cell damage in Huntington disease

Discovery of critical marker of response to gemcitabine in pancreatic cancer

Comprehensive review on sulfonylureas in the latest issue of Diabetic Hypoglycemia

Prophylactic cranial irradiation prevents early lung cancer metastases to the brain

Research looks at relationship between death rates from lung cancer and how much a person smoked

Research questions standard protocol for treating traumatic brain injury

Diet low in fat and red meat and high in fruit and veg helps prevent prostate cancer

SmartPill capsule for ulcerative colitis patients

Simple MRI test involving breathing oxygen helps determine cancer therapy success

Internet-based programs effective in treating depression – new study

Bringing life back into the bedroom for cancer survivors

New insights into locally advanced breast cancer

External beam partial breast irradiation most cost-effective treatment for women with early-stage breast cancer

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News